Perioperative corticosteroids and pancreatic surgery outcomes: a systematic review and meta-analysis combining human expertise and AI support (ChatGPT)

Updates In Surgery

by Marcello Di Martino, Andrea Saibanti, Gianluca Cassese, Mariantonietta Alagia, Fabrizio Panaro, Matteo Donadon
July 8, 2026

Conexiant

Can Belzutifan Improve Adjuvant Therapy?

The phase 3 LITESPARK-022 trial compared adjuvant pembrolizumab plus belzutifan with pembrolizumab plus placebo following resection of clear-cell renal-cell carcinoma.

by Kathryn Wighton
July 8, 2026
4 min

Frontiers In Oncology

Ectopic craniopharyngioma recurrence: a case report and literature review

by Jiarun Tian, Hongliang Zhang, Yingjie Ding, Canghao Gao, Jiaming Liu, Tiantian Guo, Huanting Li
July 8, 2026

Frontiers In Immunology

Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials

Perioperative corticosteroids and pancreatic surgery outcomes: a systematic review and meta-analysis combining human expertise and AI support (ChatGPT)

Original Source(s)

Perioperative corticosteroids and pancreatic surgery outcomes: a systematic review and meta-analysis combining human expertise and AI support (ChatGPT)

Related Content

Can Belzutifan Improve Adjuvant Therapy?

Ectopic craniopharyngioma recurrence: a case report and literature review

Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials